Armenian hamster Anti-Mouse/Rat CD61 Antibody (S-R656)

產(chǎn)品型號(hào)：S0B5020

更新時(shí)間：2025-07-12

廠商性質(zhì)：生產(chǎn)廠家

訪問(wèn)量：25

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對(duì)抗體病理/IHC抗體

查看全部產(chǎn)品

p16/Ki-67雙染：子宮頸癌前病變?cè)\斷的精準(zhǔn)之道

泛修飾“乳”此閃耀：L-乳酸化

IHC腫瘤標(biāo)志物 | 常見(jiàn)前列腺癌診斷

產(chǎn)品介紹

CD61, also known as integrin β3 or GPIIIa, is a membrane glycoprotein primarily expressed on platelets, megakaryocytes, endothelial cells, osteoclasts, and some tumor cells. It forms heterodimeric complexes with other integrins, such as CD41 （forming the GPIIb/IIIa complex） or CD51 （forming the αvβ3 integrin）, which mediate cell adhesion to various extracellular matrix proteins, including fibrinogen, fibronectin, and vitronectin. The GPIIb/IIIa complex is essential for platelet aggregation and blood clotting, while the αvβ3 integrin is involved in cell migration, invasion, and tumor metastasis. In clinical settings, CD61 is used as a biomarker to identify platelets and megakaryocytes, diagnose platelet disorders like Glanzmann thrombasthenia, and assess the risk of thrombotic events. Additionally, elevated CD61 expression in tumors is associated with poor prognosis in several cancers, including non-small cell lung cancer, breast cancer, and gliomas.

上一個(gè)：S0B5021Biotin Armenian hamster Anti-Mouse CD11c Antibody (S-R518)